Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unfractionated Heparin in Acute Chest Syndrome
NCT02098993Phase 2Terminated
- Start
- May 2014
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in acute chest syndrome (ACS). Started May 2014; status: terminated.
02
Drugs
heparin
03
Conditions
acute chest syndrome (ACS)
Beyond the preview
Go deeper on NCT02098993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098993.